-
1
-
-
55749102903
-
Impact of package leachables on the stability of pharmaceutical products
-
Allain L, Wang Q. 2007. Impact of package leachables on the stability of pharmaceutical products. Am Pharm Rev 10(4):38-44.
-
(2007)
Am Pharm Rev
, vol.10
, Issue.4
, pp. 38-44
-
-
Allain, L.1
Wang, Q.2
-
2
-
-
43349096556
-
Best practices for extractables and leachables in orally inhaled and nasal drug products: An overview of the PQRI recommendations
-
Norwood DL, Paskiet D, Ruberto M, Feinberg T, Schroeder A, Poochikian G, Wang Q, Deng TJ, DeGrazio F, Munos MK, Nagao LM. 2008. Best practices for extractables and leachables in orally inhaled and nasal drug products: An overview of the PQRI recommendations. Pharm Res 25(4):727-739.
-
(2008)
Pharm Res
, vol.25
, Issue.4
, pp. 727-739
-
-
Norwood, D.L.1
Paskiet, D.2
Ruberto, M.3
Feinberg, T.4
Schroeder, A.5
Poochikian, G.6
Wang, Q.7
Deng, T.J.8
DeGrazio, F.9
Munos, M.K.10
Nagao, L.M.11
-
3
-
-
34248597406
-
Preliminary studies of the physical stability of a glucagon-like peptide-1 derivate in the presence of metal ions
-
Christensen S, Moeller EH, Bonde C, Lilleoere AM. 2007. Preliminary studies of the physical stability of a glucagon-like peptide-1 derivate in the presence of metal ions. Eur J Pharm Biopharm 66(3):366-371.
-
(2007)
Eur J Pharm Biopharm
, vol.66
, Issue.3
, pp. 366-371
-
-
Christensen, S.1
Moeller, E.H.2
Bonde, C.3
Lilleoere, A.M.4
-
4
-
-
85030497806
-
-
Code of Federal Regulations Title 21-Subpart D-Equipment, 211.63 Equipment design, size and location.
-
Code of Federal Regulations Title 21-Subpart D-Equipment, 211.63 Equipment design, size and location.
-
-
-
-
5
-
-
33847287881
-
Profiling of metal ions leached from Pharm packaging materials
-
Fliszar KA, Walker D, Allain L. 2006. Profiling of metal ions leached from Pharm packaging materials. PDA J Pharm Sci Technol 60(6):337-342.
-
(2006)
PDA J Pharm Sci Technol
, vol.60
, Issue.6
, pp. 337-342
-
-
Fliszar, K.A.1
Walker, D.2
Allain, L.3
-
6
-
-
77957338970
-
Comparative evaluation of disodium edetate and diethylenetriaminepentaacetic acid as iron chelators to prevent metal-catalyzed destabilization of a therapeutic monoclonal antibody
-
Zhou S, Zhang B, Sturm E, Teagarden DL, Schoneich C, Kolhe P, Lewis LM, Muralidhara BK, Singh SK. 2010. Comparative evaluation of disodium edetate and diethylenetriaminepentaacetic acid as iron chelators to prevent metal-catalyzed destabilization of a therapeutic monoclonal antibody. J Pharm Sci 99(10):4239-4250.
-
(2010)
J Pharm Sci
, vol.99
, Issue.10
, pp. 4239-4250
-
-
Zhou, S.1
Zhang, B.2
Sturm, E.3
Teagarden, D.L.4
Schoneich, C.5
Kolhe, P.6
Lewis, L.M.7
Muralidhara, B.K.8
Singh, S.K.9
-
7
-
-
0022498102
-
Site-specific modification of albumin by free radicals. Reaction with copper(II) and ascorbate
-
Marx G, Chevion M. 1986. Site-specific modification of albumin by free radicals. Reaction with copper(II) and ascorbate. Biochem J 236(2):397-400.
-
(1986)
Biochem J
, vol.236
, Issue.2
, pp. 397-400
-
-
Marx, G.1
Chevion, M.2
-
8
-
-
0027980816
-
2. Selective generation of 2-oxo-histidine at the histidine 118
-
2. Selective generation of 2-oxo-histidine at the histidine 118. J Biol Chem 269(4):2405-2410.
-
(1994)
J Biol Chem
, vol.269
, Issue.4
, pp. 2405-2410
-
-
Uchida, K.1
Kawakishi, S.2
-
9
-
-
0029028559
-
Aggregation and precipitation of human relaxin induced by metal-catalyzed oxidation
-
Li S, Nguyen TH, Schoneich C, Borchardt RT. 1995. Aggregation and precipitation of human relaxin induced by metal-catalyzed oxidation. Biochemistry 34(17):5762-5772.
-
(1995)
Biochemistry
, vol.34
, Issue.17
, pp. 5762-5772
-
-
Li, S.1
Nguyen, T.H.2
Schoneich, C.3
Borchardt, R.T.4
-
10
-
-
0035941201
-
Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure
-
Uversky VN, Li J, Fink AL. 2001. Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure. J Biol Chem 276(47):44284-44296.
-
(2001)
J Biol Chem
, vol.276
, Issue.47
, pp. 44284-44296
-
-
Uversky, V.N.1
Li, J.2
Fink, A.L.3
-
11
-
-
68949142807
-
Precipitation of a monoclonal antibody by soluble tungsten
-
Bee JS, Nelson SA, Freund E, Carpenter JF, Randolph TW. 2009. Precipitation of a monoclonal antibody by soluble tungsten. J Pharm Sci 98(9):3290-3301.
-
(2009)
J Pharm Sci
, vol.98
, Issue.9
, pp. 3290-3301
-
-
Bee, J.S.1
Nelson, S.A.2
Freund, E.3
Carpenter, J.F.4
Randolph, T.W.5
-
12
-
-
0023030789
-
Sequence of a peptide susceptible to mixed-function oxidation. Probable cation binding site in glutamine synthetase
-
Farber JM, Levine RL. 1986. Sequence of a peptide susceptible to mixed-function oxidation. Probable cation binding site in glutamine synthetase. J Biol Chem 261(10):4574-4578.
-
(1986)
J Biol Chem
, vol.261
, Issue.10
, pp. 4574-4578
-
-
Farber, J.M.1
Levine, R.L.2
-
13
-
-
0027729733
-
The development of stable protein formulations: A close look at protein aggregation, deamidation, and oxidation
-
Cleland JL, Powell MF, Shire SJ. 1993. The development of stable protein formulations: A close look at protein aggregation, deamidation, and oxidation. Crit Rev Ther Drug Carrier Syst 10(4):307-377.
-
(1993)
Crit Rev Ther Drug Carrier Syst
, vol.10
, Issue.4
, pp. 307-377
-
-
Cleland, J.L.1
Powell, M.F.2
Shire, S.J.3
-
14
-
-
39749147173
-
Challenges associated with extractables and/or leachables substances in therapeutic biologic protein products
-
Markovic I. 2006. Challenges associated with extractables and/or leachables substances in therapeutic biologic protein products. Am Pharm Rev 9(6):20-27.
-
(2006)
Am Pharm Rev
, vol.9
, Issue.6
, pp. 20-27
-
-
Markovic, I.1
-
15
-
-
84862644490
-
Tungsten-induced denaturation and aggregation of epoetin alfa during primary packaging as a cause of immunogenicity
-
Seidl A, Hainzl O, Richter M, Fischer R, Bohm S, Deutel B, Hartinger M, Windisch J, Casadevall N, London GM, Macdougall I. 2011. Tungsten-induced denaturation and aggregation of epoetin alfa during primary packaging as a cause of immunogenicity. Pharm Res 29(6):1454-1467.
-
(2011)
Pharm Res
, vol.29
, Issue.6
, pp. 1454-1467
-
-
Seidl, A.1
Hainzl, O.2
Richter, M.3
Fischer, R.4
Bohm, S.5
Deutel, B.6
Hartinger, M.7
Windisch, J.8
Casadevall, N.9
London, G.M.10
Macdougall, I.11
-
16
-
-
59049106726
-
Isolation, structural determination, synthesis and quantitative determination of impurities in Intron-A, leached from a silicone tubing
-
Chan TM, Pramanik B, Aslanian R, Gullo V, Patel M, Cronin B, Boyce C, McCormick K, Berlin M, Zhu X, Buevich A, Heimark L, Bartner P, Chen G, Pu H, Hegde V. 2009. Isolation, structural determination, synthesis and quantitative determination of impurities in Intron-A, leached from a silicone tubing. J Pharm Biomed Anal 49(2):327-332.
-
(2009)
J Pharm Biomed Anal
, vol.49
, Issue.2
, pp. 327-332
-
-
Chan, T.M.1
Pramanik, B.2
Aslanian, R.3
Gullo, V.4
Patel, M.5
Cronin, B.6
Boyce, C.7
McCormick, K.8
Berlin, M.9
Zhu, X.10
Buevich, A.11
Heimark, L.12
Bartner, P.13
Chen, G.14
Pu, H.15
Hegde, V.16
-
17
-
-
0030724407
-
Antioxidants for prevention of methionine oxidation in recombinant monoclonal antibody HER2
-
Lam XM, Yang JY, Cleland JL. 1997. Antioxidants for prevention of methionine oxidation in recombinant monoclonal antibody HER2. J Pharm Sci 86(11):1250-1255.
-
(1997)
J Pharm Sci
, vol.86
, Issue.11
, pp. 1250-1255
-
-
Lam, X.M.1
Yang, J.Y.2
Cleland, J.L.3
-
18
-
-
0346846691
-
Influence of histidine on the stability and physical properties of a fully human antibody in aqueous and solid forms
-
Chen B, Bautista R, Yu K, Zapata GA, Mulkerrin MG, Chamow SM. 2003. Influence of histidine on the stability and physical properties of a fully human antibody in aqueous and solid forms. Pharm Res 20(12):1952-1960.
-
(2003)
Pharm Res
, vol.20
, Issue.12
, pp. 1952-1960
-
-
Chen, B.1
Bautista, R.2
Yu, K.3
Zapata, G.A.4
Mulkerrin, M.G.5
Chamow, S.M.6
-
19
-
-
84862889913
-
Cobalt: group VIII(9)
-
5 ed. New York: John Wiley & Sons
-
Cotton FA, Wilkinson G. 1988. Cobalt: group VIII(9). In Advanced inorganic chemistry. 5 ed. New York: John Wiley & Sons, pp 724-775.
-
(1988)
Advanced inorganic chemistry
, pp. 724-775
-
-
Cotton, F.A.1
Wilkinson, G.2
-
20
-
-
39749099893
-
Exploiting 3D structural templates for detection of metal-binding sites in protein structures
-
Goyal K, Mande SC. 2008. Exploiting 3D structural templates for detection of metal-binding sites in protein structures. Proteins 70(4):1206-1218.
-
(2008)
Proteins
, vol.70
, Issue.4
, pp. 1206-1218
-
-
Goyal, K.1
Mande, S.C.2
-
21
-
-
0023571878
-
Metal protein interactions
-
Sarkar B. 1987. Metal protein interactions. Prog Food Nutr Sci 11(3-4):363-400.
-
(1987)
Prog Food Nutr Sci
, vol.11
, Issue.3-4
, pp. 363-400
-
-
Sarkar, B.1
-
22
-
-
0021671051
-
A long-acting injectable dosage form for a somatastatin analog
-
DeYoung JL, Lien EL. 1984. A long-acting injectable dosage form for a somatastatin analog. J Parenter Sci Technol 38(6):234-236.
-
(1984)
J Parenter Sci Technol
, vol.38
, Issue.6
, pp. 234-236
-
-
DeYoung, J.L.1
Lien, E.L.2
-
23
-
-
0030959947
-
Toward understanding insulin fibrillation
-
Brange J, Andersen L, Laursen ED, Meyn G, Rasmussen E. 1997. Toward understanding insulin fibrillation. J Pharm Sci 86(5):517-525.
-
(1997)
J Pharm Sci
, vol.86
, Issue.5
, pp. 517-525
-
-
Brange, J.1
Andersen, L.2
Laursen, E.D.3
Meyn, G.4
Rasmussen, E.5
-
24
-
-
0026794132
-
Chemical stability of insulin. 3. Influence of excipients, formulation, and pH
-
Brange J, Langkjaer L. 1992. Chemical stability of insulin. 3. Influence of excipients, formulation, and pH. Acta Pharm Nord 4(3):149-158.
-
(1992)
Acta Pharm Nord
, vol.4
, Issue.3
, pp. 149-158
-
-
Brange, J.1
Langkjaer, L.2
-
25
-
-
0027828605
-
Roosdorp N Formulation and stability of recombinant alpha 1-antitrypsin
-
Vemuri S, Yu CT. 1993. Roosdorp N Formulation and stability of recombinant alpha 1-antitrypsin. Pharm Biotechnol 5:263-286.
-
(1993)
Pharm Biotechnol
, vol.5
, pp. 263-286
-
-
Vemuri, S.1
Yu, C.T.2
-
26
-
-
0032693556
-
Copper(II) complexation by pituitary adenylate cyclase activating polypeptide fragments
-
Kowalik-Jankowska T, Jasionowski M, Lankiewicz L. 1999. Copper(II) complexation by pituitary adenylate cyclase activating polypeptide fragments. J Inorg Biochem 76(1):63-70.
-
(1999)
J Inorg Biochem
, vol.76
, Issue.1
, pp. 63-70
-
-
Kowalik-Jankowska, T.1
Jasionowski, M.2
Lankiewicz, L.3
-
27
-
-
0035838471
-
Copper and zinc binding modulates the aggregation and neurotoxic properties of the prion peptide PrP106-126
-
Jobling MF, Huang X, Stewart LR, Barnham KJ, Curtain C, Volitakis I, Perugini M, White AR, Cherny RA, Masters CL, Barrow CJ, Collins SJ, Bush AI, Cappai R. 2001. Copper and zinc binding modulates the aggregation and neurotoxic properties of the prion peptide PrP106-126. Biochemistry 40(27):8073-8084.
-
(2001)
Biochemistry
, vol.40
, Issue.27
, pp. 8073-8084
-
-
Jobling, M.F.1
Huang, X.2
Stewart, L.R.3
Barnham, K.J.4
Curtain, C.5
Volitakis, I.6
Perugini, M.7
White, A.R.8
Cherny, R.A.9
Masters, C.L.10
Barrow, C.J.11
Collins, S.J.12
Bush, A.I.13
Cappai, R.14
-
28
-
-
14844303871
-
General strategies for efficient adjuvant incorporation of recombinant subunit immunogens
-
Wikman M, Friedman M, Pinitkiatisakul S, Andersson C, Hemphill A, Lovgren-Bengtsson K, Lunden A, Stahl S. 2005. General strategies for efficient adjuvant incorporation of recombinant subunit immunogens. Vaccine 23(17-18):2331-2335.
-
(2005)
Vaccine
, vol.23
, Issue.17-18
, pp. 2331-2335
-
-
Wikman, M.1
Friedman, M.2
Pinitkiatisakul, S.3
Andersson, C.4
Hemphill, A.5
Lovgren-Bengtsson, K.6
Lunden, A.7
Stahl, S.8
-
29
-
-
34147188155
-
Immunogenicity and protective effect against murine cerebral neosporosis of recombinant NcSRS2 in different iscom formulations
-
Pinitkiatisakul S, Friedman M, Wikman M, Mattsson JG, Lovgren-Bengtsson K, Stahl S, Lunden A. 2007. Immunogenicity and protective effect against murine cerebral neosporosis of recombinant NcSRS2 in different iscom formulations. Vaccine 25(18):3658-3668.
-
(2007)
Vaccine
, vol.25
, Issue.18
, pp. 3658-3668
-
-
Pinitkiatisakul, S.1
Friedman, M.2
Wikman, M.3
Mattsson, J.G.4
Lovgren-Bengtsson, K.5
Stahl, S.6
Lunden, A.7
-
30
-
-
0035975923
-
Perspectives of immobilized-metal affinity chromatography
-
Gaberc-Porekar V, Menart V. 2001. Perspectives of immobilized-metal affinity chromatography. J Biochem Biophys Methods 49(1-3):335-360.
-
(2001)
J Biochem Biophys Methods
, vol.49
, Issue.1-3
, pp. 335-360
-
-
Gaberc-Porekar, V.1
Menart, V.2
-
31
-
-
3142774200
-
Effect of metal ions on de novo aggregation of full-length prion protein
-
Giese A, Levin J, Bertsch U, Kretzschmar H. 2004. Effect of metal ions on de novo aggregation of full-length prion protein. Biochem Biophys Res Commun 320(4):1240-1246.
-
(2004)
Biochem Biophys Res Commun
, vol.320
, Issue.4
, pp. 1240-1246
-
-
Giese, A.1
Levin, J.2
Bertsch, U.3
Kretzschmar, H.4
-
32
-
-
37349110384
-
A novel method for study of the aggregation of protein induced by metal ion aluminum(III) using resonance Rayleigh scattering technique
-
Long X, Zhang C, Cheng J, Bi S. 2008. A novel method for study of the aggregation of protein induced by metal ion aluminum(III) using resonance Rayleigh scattering technique. Spectrochim Acta A Mol Biomol Spectrosc 69(1):71-77.
-
(2008)
Spectrochim Acta A Mol Biomol Spectrosc
, vol.69
, Issue.1
, pp. 71-77
-
-
Long, X.1
Zhang, C.2
Cheng, J.3
Bi, S.4
-
33
-
-
4844230143
-
Effect of metal cations on the conformation and inactivation of recombinant human factor VIII
-
Derrick TS, Kashi RS, Durrani M, Jhingan A, Middaugh CR. 2004. Effect of metal cations on the conformation and inactivation of recombinant human factor VIII. J Pharm Sci 93(10):2549-2557.
-
(2004)
J Pharm Sci
, vol.93
, Issue.10
, pp. 2549-2557
-
-
Derrick, T.S.1
Kashi, R.S.2
Durrani, M.3
Jhingan, A.4
Middaugh, C.R.5
|